TOPIX Pharmaceuticals, Inc. Partners with the University of Minnesota, Center for Drug Design to Develop Groundbreaking ProteXidine Molecule ...Middle East

Clinical evidence suggests that this first-in-class technology enhances the skin's innate ability to manage UV-induced damage NEW YORK, June 5, 2024 /PRNewswire/ -- According to the Skin Cancer Foundation, 90% of skin aging is caused by the sun,1 and even with proper SPF usage, harmful UV...

Hence then, the article about topix pharmaceuticals inc partners with the university of minnesota center for drug design to develop groundbreaking protexidine molecule was published today ( Wednesday 05/06/2024 - 03:09 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( TOPIX Pharmaceuticals, Inc. Partners with the University of Minnesota, Center for Drug Design to Develop Groundbreaking ProteXidine Molecule )

Also on site :

• Russia-Ukraine war: List of key events, day 1,428
• Thrash Metal Icon Reveals Truth About Final Album of 43-Year-Old Band
• Christina Haack Stuns in Bikini With Boyfriend on Tropical Getaway